Clinical trial
A Randomized, Controlled, Open-label Study of the Safety and Efficacy of Ferrlecit® vs Oral Iron in Iron Deficient Patients With Chronic Kidney Disease
NCT00224055 is registered in ClinicalTrials.gov with Watson Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Open-label Study of the Safety and Efficacy of Ferrlecit® vs Oral Iron in Iron Deficient Patients With Chronic Kidney Disease
- Lead sponsor
- Watson Pharmaceuticals
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2003
- Completion date
- September 30, 2004
- Enrollment
- 89 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.